These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 12169142)
1. A symposium on Attention Deficit Hyperactivity Disorder (ADHD). Developments in treatment. Levy F Aust N Z J Psychiatry; 2002 Aug; 36(4):477-9. PubMed ID: 12169142 [No Abstract] [Full Text] [Related]
2. A symposium on Attention Deficit Hyperactivity Disorder (ADHD). Four pertinent issues in treatment. Luk ES Aust N Z J Psychiatry; 2002 Aug; 36(4):479-81. PubMed ID: 12169143 [No Abstract] [Full Text] [Related]
3. A symposium on Attention Deficit Hyperactivity Disorder (ADHD). 'Kid in the corner'. Hazell P Aust N Z J Psychiatry; 2002 Aug; 36(4):475-7. PubMed ID: 12169141 [No Abstract] [Full Text] [Related]
4. Pemoline in ADHD. Winsberg B; Barbato M J Am Acad Child Adolesc Psychiatry; 1997 Dec; 36(12):1649-50. PubMed ID: 9401321 [No Abstract] [Full Text] [Related]
5. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder. Pae CU Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730 [No Abstract] [Full Text] [Related]
6. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. Aman MG; Binder C; Turgay A J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021 [TBL] [Abstract][Full Text] [Related]
7. Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder. Marcus SC; Durkin M J Am Acad Child Adolesc Psychiatry; 2011 May; 50(5):480-9. PubMed ID: 21515197 [TBL] [Abstract][Full Text] [Related]
8. Medications used in the treatment of disruptive behavior in children with FASD--a guide. Ozsarfati J; Koren G J Popul Ther Clin Pharmacol; 2015; 22(1):e59-67. PubMed ID: 25715382 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders]. Wiesegger G; Kienbacher C; Pellegrini E; Scheidinger H; Vesely C; Bangerl W; Friedrich M Neuropsychiatr; 2007; 21(3):187-206. PubMed ID: 17915180 [TBL] [Abstract][Full Text] [Related]
10. OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study. Marchant BK; Reimherr FW; Halls C; Williams ED; Strong RE Ann Clin Psychiatry; 2010 Aug; 22(3):196-204. PubMed ID: 20680193 [TBL] [Abstract][Full Text] [Related]
11. [Attention deficit hyperactivity disorder in adults. An overview]. Sobanski E; Alm B Nervenarzt; 2004 Jul; 75(7):697-715; quiz 716. PubMed ID: 15221066 [TBL] [Abstract][Full Text] [Related]
12. A symposium on Attention Deficit Hyperactivity Disorder (ADHD). Towards an integrative developmental model. Vance AL Aust N Z J Psychiatry; 2002 Aug; 36(4):485-7. PubMed ID: 12169146 [No Abstract] [Full Text] [Related]
13. Disruptive and oppositional behavior in an 11-year old boy. Garland A; Augustyn M; Stein MT J Dev Behav Pediatr; 2007 Oct; 28(5):406-8. PubMed ID: 18049326 [No Abstract] [Full Text] [Related]
14. The Relationship between Acute Dyskinesia with a Single Dose of Methylphenidate and Recent Risperidone Discontinuation in a Child with Attention-Deficit/Hyperactivity Disorder. Ince E; Algedik P; Demirdogen ES; Emul M; Demir T J Child Adolesc Psychopharmacol; 2015 May; 25(4):378-9. PubMed ID: 25920038 [No Abstract] [Full Text] [Related]
15. Hallucinations in children and adolescents: considerations in the emergency setting. Edelsohn GA Am J Psychiatry; 2006 May; 163(5):781-5. PubMed ID: 16648315 [No Abstract] [Full Text] [Related]
16. Self-handicapping prior to academic-oriented tasks in children with attention deficit/hyperactivity disorder (ADHD): medication effects and comparisons with controls. Waschbusch DA; Craig R; Pelham WE; King S J Abnorm Child Psychol; 2007 Apr; 35(2):275-86. PubMed ID: 17195950 [TBL] [Abstract][Full Text] [Related]